Table 4

Association of drug requirements for CVD prevention among the study population as per total CVD risk assessment, with and without cholesterol, and single risk factor line

Approaches	Variants	Participants (n=563)
		Persons requiring drugs
		Threshold ≥30%		Threshold ≥20%
		No.	%	No.	%
Total CVD risk without cholesterol	Elevated risk per charts alone	32	5.7	62	11.07
	Charts normal with BP ≥160/100	2	0.36	2	0.36
	Total	34*	6.06†	64‡	11.43†
Total CVD risk with cholesterol	Elevated risk per charts alone	20	3.55	44	7.82
	Charts normal with BP ≥160/100	2	0.36	2	0.36
	Charts normal with TC ≥8	1	0.18	1	0.18
	Total	23§	4.09¶	47**	8.35¶
Single risk factor	BP ≥140/90	57*	10.1	57‡	10.1
	TC ≥6	102	18.1	102	18.1
	Total	159§	28.2	159**	28.2

*Without cholesterol versus single risk factor, threshold ≥30%: χ²=6.32, p<0.012.
†Without cholesterol, threshold ≥30% versus without cholesterol, threshold ≥20%: χ²=10.06, p<0.002.
‡Without cholesterol versus single risk factor, threshold ≥20%: χ²=0.45, p<0.500.
§ With cholesterol versus single risk factor, threshold ≥30%: χ²=123.9, p<0.001.
¶With cholesterol, threshold ≥30% versus with cholesterol, threshold ≥20%: χ²=8.77, p<0.003.
**With cholesterol versus single risk factor, threshold ≥20%: χ²=74.5, p<0.001.
BP, blood pressure; CVD, cardiovascular disease; TC, total cholesterol.